Clinical Trial Update: Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) [Phase 2]

View source ↗

Summary

AR08's Phase 2 safety and efficacy study for vasomotor symptoms has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• AR08

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Vasomotor Symptoms (VMS) | Phase 2 | Status: TERMINATED